Found: 101
Select item for more details and to access through your institution.
Inhibition of Cdk2 kinase activity selectively targets the CD44<sup>+</sup>/CD24<sup>-/Low</sup> stem-like subpopulation and restores chemosensitivity of SUM149PT triple-negative breast cancer cells.
- Published in:
- International Journal of Oncology, 2014, v. 45, n. 3, p. 1193, doi. 10.3892/ijo.2014.2523
- By:
- Publication type:
- Article
Aurora-A Kinase as a Promising Therapeutic Target in Cancer.
- Published in:
- Frontiers in Oncology, 2016, v. 5, p. 1, doi. 10.3389/fonc.2015.00295
- By:
- Publication type:
- Article
Examiner accuracy in cognitive testing in multisite brain-tumor clinical trials: an analysis from the Alliance for Clinical Trials in Oncology.
- Published in:
- Neuro-Oncology Practice, 2019, v. 6, n. 4, p. 283, doi. 10.1093/nop/npy048
- By:
- Publication type:
- Article
The future of cancer immunotherapy for brain tumors: a collaborative workshop.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Carcinoembryonic antigen-expressing oncolytic measles virus derivative in recurrent glioblastoma: a phase 1 trial.
- Published in:
- Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-023-43076-7
- By:
- Publication type:
- Article
Aurora-A Mitotic Kinase Induces Endocrine Resistance through Down-Regulation of ERα Expression in Initially ERα+ Breast Cancer Cells.
- Published in:
- PLoS ONE, 2014, v. 9, n. 5, p. 1, doi. 10.1371/journal.pone.0096995
- By:
- Publication type:
- Article
Targeting Src Family Kinases Inhibits Bevacizumab-Induced Glioma Cell Invasion.
- Published in:
- PLoS ONE, 2013, v. 8, n. 2, p. 1, doi. 10.1371/journal.pone.0056505
- By:
- Publication type:
- Article
Incorporation of Prognostic and Predictive Factors Into Glioma Clinical Trials.
- Published in:
- Current Oncology Reports, 2013, v. 15, n. 1, p. 56, doi. 10.1007/s11912-012-0279-z
- By:
- Publication type:
- Article
Incorporation of Biomarker Assessment in Novel Clinical Trial Designs: Personalizing Brain Tumor Treatments.
- Published in:
- Current Oncology Reports, 2011, v. 13, n. 1, p. 42, doi. 10.1007/s11912-010-0144-x
- By:
- Publication type:
- Article
Tailoring Chemotherapy for Low-Grade Gliomas.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
Tailoring Chemotherapy for Low-Grade Gliomas.
- Published in:
- Oncology (08909091), 2014, v. 28, n. 12, p. 1052
- By:
- Publication type:
- Article
PARP Inhibitors in Glioma: A Review of Therapeutic Opportunities.
- Published in:
- Cancers, 2022, v. 14, n. 4, p. 1003, doi. 10.3390/cancers14041003
- By:
- Publication type:
- Article
The Alliance AMBUSH Trial: Rationale and Design.
- Published in:
- Cancers, 2022, v. 14, n. 2, p. 414, doi. 10.3390/cancers14020414
- By:
- Publication type:
- Article
Management of recurrent meningeal hemangiopericytoma.
- Published in:
- Cancer (0008543X), 1998, v. 82, n. 10, p. 1915, doi. 10.1002/(SICI)1097-0142(19980515)82:10<1915::AID-CNCR15>3.0.CO;2-W
- By:
- Publication type:
- Article
Extrapulmonary small cell carcinoma.
- Published in:
- 1997
- By:
- Publication type:
- journal article
Phase I/II trial of pyrazoloacridine and carboplatin in patients with recurrent glioma: A North Central Cancer Treatment Group trial.
- Published in:
- Investigational New Drugs, 2005, v. 23, n. 5, p. 495, doi. 10.1007/s10637-005-2910-4
- By:
- Publication type:
- Article
Demonstration of anti-tumor activity of oncolytic measles virus strains in a malignant pleural effusion breast cancer model.
- Published in:
- Breast Cancer Research & Treatment, 2010, v. 122, n. 3, p. 745, doi. 10.1007/s10549-009-0602-z
- By:
- Publication type:
- Article
Cancer: Tumour-fighting virus homes in.
- Published in:
- Nature, 2011, v. 477, n. 7362, p. 40, doi. 10.1038/477040a
- By:
- Publication type:
- Article
Phase II Trial of Intravenous Administration of Reolysin<sup>®</sup> (Reovirus Serotype-3-dearing Strain) in Patients with Metastatic Melanoma.
- Published in:
- Molecular Therapy, 2012, v. 20, n. 10, p. 1998, doi. 10.1038/mt.2012.146
- By:
- Publication type:
- Article
Expression of Immunomodulatory Neutrophil-activating Protein of Helicobacter pylori Enhances the Antitumor Activity of Oncolytic Measles Virus.
- Published in:
- Molecular Therapy, 2012, v. 20, n. 6, p. 1139, doi. 10.1038/mt.2012.4
- By:
- Publication type:
- Article
Report of National Brain Tumor Society roundtable workshop on innovating brain tumor clinical trials: building on lessons learned from COVID-19 experience.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 8, p. 1252, doi. 10.1093/neuonc/noab082
- By:
- Publication type:
- Article
CODEL: phase III study of RT, RT + TMZ, or TMZ for newly diagnosed 1p/19q codeleted oligodendroglioma. Analysis from the initial study design.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 3, p. 457, doi. 10.1093/neuonc/noaa168
- By:
- Publication type:
- Article
Consensus recommendations for a dynamic susceptibility contrast MRI protocol for use in high-grade gliomas.
- Published in:
- Neuro-Oncology, 2020, v. 22, n. 9, p. 1262, doi. 10.1093/neuonc/noaa141
- By:
- Publication type:
- Article
Response to Letter to Editor.
- Published in:
- Neuro-Oncology, 2020, v. 22, n. 11, p. 1706, doi. 10.1093/neuonc/noaa202
- By:
- Publication type:
- Article
Phase 0 and window of opportunity clinical trial design in neuro-oncology: a RANO review.
- Published in:
- Neuro-Oncology, 2020, v. 22, n. 11, p. 1568, doi. 10.1093/neuonc/noaa149
- By:
- Publication type:
- Article
Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions.
- Published in:
- Neuro-Oncology, 2020, v. 22, n. 8, p. 1073, doi. 10.1093/neuonc/noaa106
- By:
- Publication type:
- Article
Consensus recommendations for a standardized brain tumor imaging protocol for clinical trials in brain metastases.
- Published in:
- Neuro-Oncology, 2020, v. 22, n. 6, p. 757, doi. 10.1093/neuonc/noaa030
- By:
- Publication type:
- Article
Final report from Intergroup NCCTG 86-72-51 (Alliance): a phase III randomized clinical trial of high-dose versus low-dose radiation for adult low-grade glioma.
- Published in:
- Neuro-Oncology, 2020, v. 22, n. 6, p. 830, doi. 10.1093/neuonc/noaa021
- By:
- Publication type:
- Article
Optimizing eligibility criteria and clinical trial conduct to enhance clinical trial participation for primary brain tumor patients.
- Published in:
- Neuro-Oncology, 2020, v. 22, n. 5, p. 601, doi. 10.1093/neuonc/noaa015
- By:
- Publication type:
- Article
The medical necessity of advanced molecular testing in the diagnosis and treatment of brain tumor patients.
- Published in:
- Neuro-Oncology, 2019, v. 21, n. 12, p. 1498, doi. 10.1093/neuonc/noz119
- By:
- Publication type:
- Article
Barriers to accrual and enrollment in brain tumor trials.
- Published in:
- Neuro-Oncology, 2019, v. 21, n. 9, p. 1100, doi. 10.1093/neuonc/noz104
- By:
- Publication type:
- Article
Advances in multidisciplinary therapy for meningiomas.
- Published in:
- Neuro-Oncology, 2019, v. 21, p. i18, doi. 10.1093/neuonc/noy136
- By:
- Publication type:
- Article
Proposed response assessment and endpoints for meningioma clinical trials: report from the Response Assessment in Neuro-Oncology Working Group.
- Published in:
- Neuro-Oncology, 2019, v. 21, n. 1, p. 26, doi. 10.1093/neuonc/noy137
- By:
- Publication type:
- Article
Phase I/II trial of vorinostat combined with temozolomide and radiation therapy for newly diagnosed glioblastoma: results of Alliance N0874/ABTC 02.
- Published in:
- Neuro-Oncology, 2018, v. 20, n. 4, p. 546, doi. 10.1093/neuonc/nox161
- By:
- Publication type:
- Article
Is the blood-brain barrier really disrupted in all glioblastomas? A critical assessment of existing clinical data.
- Published in:
- Neuro-Oncology, 2018, v. 20, n. 2, p. 184, doi. 10.1093/neuonc/nox175
- By:
- Publication type:
- Article
The Neurologic Assessment in Neuro-Oncology (NANO) scale: a tool to assess neurologic function for integration into the Response Assessment in Neuro-Oncology (RANO) criteria.
- Published in:
- Neuro-Oncology, 2017, v. 19, n. 5, p. 625, doi. 10.1093/neuonc/nox029
- By:
- Publication type:
- Article
Immunovirotherapy with measles virus strains in combination with anti-PD-1 antibody blockade enhances antitumor activity in glioblastoma treatment.
- Published in:
- Neuro-Oncology, 2017, v. 19, n. 4, p. 493, doi. 10.1093/neuonc/now179
- By:
- Publication type:
- Article
Where size matters: imaging-based biomarkers for patient stratification.
- Published in:
- Neuro-Oncology, 2017, v. 19, n. 1, p. 7, doi. 10.1093/neuonc/now248
- By:
- Publication type:
- Article
A phase II trial of everolimus, temozolomide, and radiotherapy in patients with newly diagnosed glioblastoma: NCCTG N057K.
- Published in:
- Neuro-Oncology, 2015, v. 17, n. 9, p. 1261, doi. 10.1093/neuonc/nou328
- By:
- Publication type:
- Article
Consensus recommendations for a standardized Brain Tumor Imaging Protocol in clinical trials.
- Published in:
- Neuro-Oncology, 2015, v. 17, n. 9, p. 1188, doi. 10.1093/neuonc/nov095
- By:
- Publication type:
- Article
Brain Malignancy Steering Committee clinical trials planning workshop: Report from the Targeted Therapies Working Group.
- Published in:
- Neuro-Oncology, 2015, v. 17, n. 2, p. 180, doi. 10.1093/neuonc/nou154
- By:
- Publication type:
- Article
New validated prognostic models and prognostic calculators in patients with low-grade gliomas diagnosed by central pathology review: a pooled analysis of EORTC/RTOG/NCCTG phase III clinical trials.
- Published in:
- Neuro-Oncology, 2013, v. 15, n. 11, p. 1568, doi. 10.1093/neuonc/not117
- By:
- Publication type:
- Article
Oncolytic measles virus prolongs survival in a murine model of cerebral spinal fluid–disseminated medulloblastoma.
- Published in:
- Neuro-Oncology, 2012, v. 14, n. 4, p. 459, doi. 10.1093/neuonc/nor231
- By:
- Publication type:
- Article
Phase II trial of vorinostat in combination with bortezomib in recurrent glioblastoma: a north central cancer treatment group study.
- Published in:
- Neuro-Oncology, 2012, v. 14, n. 2, p. 215, doi. 10.1093/neuonc/nor198
- By:
- Publication type:
- Article
Clinical trial end points for high-grade glioma: the evolving landscape*.
- Published in:
- Neuro-Oncology, 2011, v. 13, n. 3, p. 353, doi. 10.1093/neuonc/noq203
- By:
- Publication type:
- Article
Treatment of medulloblastoma with a modified measles virus.
- Published in:
- Neuro-Oncology, 2010, v. 12, n. 10, p. 1034, doi. 10.1093/neuonc/noq057
- By:
- Publication type:
- Article
Validation of neuroradiologic response assessment in gliomas: Measurement by RECIST, two-dimensional, computer-assisted tumor area, and computer-assisted tumor volume methods.
- Published in:
- Neuro-Oncology, 2006, v. 8, n. 2, p. 156, doi. 10.1215/15228517-2005-005
- By:
- Publication type:
- Article
Patient tumor EGFR and PDGFRA gene amplifications retained in an invasive intracranial xenograft model of glioblastoma multiforme.
- Published in:
- Neuro-Oncology, 2005, v. 7, n. 2, p. 164, doi. 10.1215/S1152851704000821
- By:
- Publication type:
- Article
An Update on the Clinical Status, Challenges, and Future Directions of Oncolytic Virotherapy for Malignant Gliomas.
- Published in:
- Current Treatment Options in Oncology, 2024, v. 25, n. 7, p. 952, doi. 10.1007/s11864-024-01211-6
- By:
- Publication type:
- Article
High-dose Chemotherapy With Autologous Stem Cell Transplantation in Adults With Recurrent Embryonal Tumors of the Central Nervous System.
- Published in:
- Cancer (0008543X), 2008, v. 112, n. 8, p. 1805, doi. 10.1002/cncr.23362
- By:
- Publication type:
- Article